WS #11711

From 498 msgs · 8 key-dev

AstraZeneca and Ionis' Wainua fails Phase 3 ATTR-CM trial, causing AZN stock to slump 11% and IONS to plummet; competitors ALNY and BBIO surge.

AstraZeneca/Ionis Drug Trial Failure

AstraZeneca and Ionis' Wainua fails Phase 3 ATTR-CM trial, causing AZN stock to slump 11% and IONS to plummet; competitors ALNY and BBIO surge.

Full world state #11711 →

AstraZeneca/Ionis Drug Trial Failure — World state #11711 · River